Suppr超能文献

改良克罗恩病活动指数在肠造口术患者中的评价:一项单中心观察性研究。

Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: A single-center observational study.

机构信息

First Department of Medicine.

Department of Endoscopic and Photodynamic Medicine.

出版信息

Medicine (Baltimore). 2021 Feb 12;100(6):e24717. doi: 10.1097/MD.0000000000024717.

Abstract

Although the Crohn's Disease Activity Index (CDAI) is often used to evaluate the disease activity in Crohn's disease (CD), the number of liquid or soft stools cannot be precisely evaluated, and thus accurate scores cannot be calculated, in patients with enterostomy. Therefore, we created the modified CDAI (mCDAI), without the defecation frequency item from the CDAI, and examined its usefulness.Study participants comprised 9 patients with CD with enterostomy and 20 patients with CD without enterostomy. Correlations between the mCDAI and serum albumin (Alb) levels or C-reactive protein (CRP) levels were examined using regression analysis. Additionally, regression analyses were conducted in patients with CD without enterostomy to determine the Alb and CRP levels corresponding to the CDAI at its cutoff value for remission status (150). The obtained values were applied to the mCDAI regression equations to determine the equivalent mCDAI cutoff value.mCDAI and Alb levels were significantly negatively correlated (P < .0001). The mCDAI had a significant positive correlation with the CRP level and erythrocyte sedimentation rate (P = .0061 and P = .0133, respectively). From the regression analysis of patients with CD without enterostomy, the Alb and CRP levels equivalent to a CDAI of 150 were 3.85 g/dL and 0.62 mg/dL, respectively. When applying these values to the mCDAI regression formulas, the values of 113.8 and 115.2, respectively, were obtained. Thus, the cutoff value of the mCDAI indicating disease activity was estimated as 115.The mCDAI fully reflects the nutritional status and inflammatory response, and is convenient and useful for assessing disease activity over time, in patients with CD with enterostomy. A mCDAI score ≥ 115 indicates disease activity.

摘要

虽然克罗恩病活动指数(CDAI)常用于评估克罗恩病(CD)的疾病活动度,但对于存在肠造口的患者,无法准确评估其液体或软便的次数,因此无法准确计算分数。因此,我们创建了改良 CDAI(mCDAI),即从 CDAI 中删除排便频率项,并对其有效性进行了研究。

研究对象包括 9 例存在肠造口的 CD 患者和 20 例无肠造口的 CD 患者。使用回归分析研究 mCDAI 与血清白蛋白(Alb)水平或 C 反应蛋白(CRP)水平之间的相关性。此外,还对无肠造口的 CD 患者进行回归分析,以确定 Alb 和 CRP 水平与 CDAI 缓解状态(150)的截止值相对应。将获得的值应用于 mCDAI 回归方程,以确定等效的 mCDAI 截止值。mCDAI 与 Alb 水平呈显著负相关(P<0.0001)。mCDAI 与 CRP 水平和红细胞沉降率呈显著正相关(P=0.0061 和 P=0.0133)。从无肠造口的 CD 患者的回归分析中,相当于 CDAI 为 150 的 Alb 和 CRP 水平分别为 3.85g/dL 和 0.62mg/dL。当将这些值应用于 mCDAI 回归公式时,分别得到 113.8 和 115.2 的值。因此,mCDAI 指示疾病活动的截止值估计为 115。

mCDAI 充分反映了营养状况和炎症反应,对于评估存在肠造口的 CD 患者随时间推移的疾病活动度,方便且有用。mCDAI 评分≥115 表示疾病活动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b2/10545123/38586194e168/medi-100-e24717-g001.jpg

相似文献

2
CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Clin Chim Acta. 2013 Jun 5;421:31-3. doi: 10.1016/j.cca.2013.02.016. Epub 2013 Feb 26.
3
Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
Dig Dis Sci. 2015 Nov;60(11):3418-23. doi: 10.1007/s10620-015-3745-2. Epub 2015 Jun 16.
7
Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
World J Gastroenterol. 2017 Dec 14;23(46):8235-8247. doi: 10.3748/wjg.v23.i46.8235.
8
A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71. doi: 10.1016/j.cgh.2013.06.021. Epub 2013 Jul 19.
9
Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease.
World J Gastroenterol. 2019 May 21;25(19):2354-2364. doi: 10.3748/wjg.v25.i19.2354.
10
Elevated Levels of IL-27 Are Associated with Disease Activity in Patients with Crohn's Disease.
Mediators Inflamm. 2021 Oct 26;2021:5527627. doi: 10.1155/2021/5527627. eCollection 2021.

本文引用的文献

1
Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease.
Clin Transl Gastroenterol. 2019 Mar;10(3):e00015. doi: 10.14309/ctg.0000000000000015.
3
Modern management of perianal fistulas in Crohn's disease: future directions.
Gut. 2018 Jun;67(6):1181-1194. doi: 10.1136/gutjnl-2017-314918. Epub 2018 Jan 13.
4
Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn's disease.
PLoS One. 2017 Jun 16;12(6):e0179266. doi: 10.1371/journal.pone.0179266. eCollection 2017.
5
Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.
Therap Adv Gastroenterol. 2017 Jun;10(6):453-463. doi: 10.1177/1756283X17698089. Epub 2017 Mar 28.
6
Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.
Curr Treat Options Gastroenterol. 2017 Mar;15(1):116-125. doi: 10.1007/s11938-017-0130-6.
7
Crohn's disease.
Lancet. 2017 Apr 29;389(10080):1741-1755. doi: 10.1016/S0140-6736(16)31711-1. Epub 2016 Dec 1.
8
Elevated C-reactive protein is associated with disease progression in patients with mild Crohn's disease.
Springerplus. 2016 Jun 24;5(1):878. doi: 10.1186/s40064-016-2606-6. eCollection 2016.
9
Measuring disease activity in Crohn's disease: what is currently available to the clinician.
Clin Exp Gastroenterol. 2014 May 20;7:151-61. doi: 10.2147/CEG.S41413. eCollection 2014.
10
Treat to target: a proposed new paradigm for the management of Crohn's disease.
Clin Gastroenterol Hepatol. 2015 Jun;13(6):1042-50.e2. doi: 10.1016/j.cgh.2013.09.006. Epub 2013 Sep 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验